CAPG, together with ANXA5 and FABP4, was previously found within a group of biomarkers differentiating invasive from noninvasive MM rat tumor models, their abundance being very significantly increased and decreased, respectively [4]. The gene discussed is ANXA5; the disease is Miyoshi myopathy.